Pedal Artery Angioplasty: Beneficial in Critical Limb Ischemia

Courtesy of Dr. Carlos Fava.

Pedal Artery Angioplasty: Beneficial in Critical Limb Ischemia

Delaying or failing to heal trophic wounds in critical limb ischemia (CLI) changes quality of life, delays rehabilitation and is associated to infections and amputation.

 

Pedal artery revascularization with angioplasty would speed up recovery and improve CLI wound healing.

 

The study analyzed 257 patients with de novo infrapopliteal lesions receiving PCI for CLI. 140 of these patients (54.5%) received pedal artery angioplasty (PAA).

 

Mean age was 73, all patients were in Rutherford class 5 or 6, and one third of patients presented >3 mg/dl creatinine. There were no differences in type, location depth or infection of trophic wounds.

 

Angiosome direct revascularization was successful in 60.3% of the population. In PAA patients, ankle brachial index (0.88 vs. 0.81; p=0.004) and skin perfusion pressure was higher (49.3 mmHg vs. 41.9 mmHg; p=0.02).

 

At one year follow up, limb salvage was 88.5% and amputation free survival rate was 73.5%. Wound resolution was 49.5%. In the moderate risk group, pedal artery revascularization saw better resolution of trophic wounds and better time to wound healing (59.3% vs. 38.1%; p=0.003 y 211 vs. 365 days; p=0.008).

 

Independent predictors of delayed healing were:

  • non ambulatory status
  • wound depth (UT ≥2)
  • the need for hemodialysis

 

Conclusion

Patients receiving pedal artery angioplasty showed higher trophic wound healing and better time to healing. As regards wound healing, this aggressive strategy could become a salvage procedure for patients with CLI and pedal artery disease.

 

Editorial Comment

Critical Limb Ischemia is on the rise, and in this analysis, a more aggressive angioplasty procedure showed benefits, especially in high risk groups.

 

It is important to have programs for this group of patients and to familiarize with wound classification, depth and infection presence (UT and WIFI classifications) to be able to better assess strategies.

 

Courtesy of Dr. Carlos Fava. Favaloro Foundation, Buenos Aires, Argentina.

 

Original Title: Clinical Outcome of Pedal Artery Angioplasty for Patients with Ischemic Wounds

Results from the Multicenter RENDEZVOUZ Registry.

Reference: Tatsuya Nakama, et al. J Am Coll Cardiol Intv 2017;10:79-90.


Suscríbase a nuestro newsletter semanal

Reciba resúmenes con los últimos artículos científicos

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....

Chronic Thromboembolic Pulmonary Hypertension: Treatment Outcomes According to a Worldwide Registry

Chronic thromboembolic pulmonary hypertension (CTEPH) is a highly limiting condition that, despite its moderate incidence, significantly impacts patient prognosis and quality of life. The...

Contemporary Outcomes of Acute Limb Ischemia Endovascular Revascularization

Acute limb ischemia (ALI) is a vascular emergency with high mortality rate. It has been defined as a sudden occlusion of limb perfusion compromising...

TCT 2024 | SIRONA: Randomized Study Comparing Sirolimus-Coated vs Paclitaxel-Coated Balloon Angioplasty in Femoropopliteal Disease

This prospective, randomized, multicenter, investigator-initiated non-inferiority study compared the use of sirolimus-coated balloon (MagicTouch) vs paclitaxel-coated balloon in endovascular treatment.  The primary objective was to...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Long Term Results of the International Chimney Registry

The International Chimney Registry was an observational study aimed at assessing the use of chimney stenting during TAVR either to predict or treat coronary...

CANNULATE TAVR extended study: Impact of Commissural and Coronary Alignment in Coronary Cannulation Following TAVR with Evolut Fx

The new valve Evolut FX has shown better commissural alignment vs. its predecessor Evolut Pro+. Prior studies have already shown commissure alignment facilitates post...

TRISCEND II: Transcatheter Replacement vs. Medical Treatment for Tricuspid Regurgitation

The EVOQUE device is designed with an intra-annular sealing system that provides excellent anatomical compatibility and an adaptable shape. It is currently available in...